chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pneumonia staphylococcal, Pulmonary embolism, Respiratory syncytial virus infection, SARS-CoV-2 test positive, Superinfection
Clinical narrative: 01/15/23 presents to ED for "SOB". PMHx of "CKD stage III, PE on Eliquis (December 2022), chronic hypoxic respiratory failure status post RSV with superimposed MRSA pneumonia (November 2022), asthma, bronchiectasis, IgA deficiency, CVA with PFO, HFpEF, COVID-19 pneumonia"
Age: 64.0
Sex: M
Vaccine: COVID19-2
Symptoms: Blood calcium increased, Cardiac disorder, Cardiac stress test abnormal, Chest X-ray abnormal, Electrocardiogram abnormal
Clinical narrative: I had a chest x-ray and the doctor saw calcium around my heart chamber. He had me take a calcium score, it was high and he bad. I was sent to a cardiologist. He ordered a stress test and I have an Abnormal EKG and they now want catharize my heart. I go into that next week. I had no symptoms.
Age: 2.0
Sex: M
Vaccine: COVID19-2
Symptoms: Abnormal behaviour, Lethargy, Rash
Clinical narrative: My son received the Pfizer Covid booster on 1/31 at 10:15 AM.  I had to wake up him the following morning and he was very lethargic and wanted to lay on the floor (very unlike him).  After getting him up, noticed wheel-shaped rash on the side of his stomach and back.  This lasted until the following day on 2/2.  The rash has not returned as of 2/10/23.
Age: 92.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cardiovascular symptom
Clinical narrative: Case presented to hospital with "heart attack like symptoms". Family members thought that she may be having a stroke.
Age: 78.0
Sex: M
Vaccine: COVID19-2
Symptoms: Unevaluable event
Clinical narrative: None stated.
Age: 92.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19-2
Symptoms: COVID-19, Dizziness, SARS-CoV-2 test positive
Clinical narrative: 01/15/23 presents to ED for "lightheadedness". PMHx "HLD, overactive bladder"
Age: 74.0
Sex: U
Vaccine: COVID19-2
Symptoms: Product storage error
Clinical narrative: temp exlusion
Age: 26.0
Sex: M
Vaccine: COVID19-2
Symptoms: Urticaria
Clinical narrative: Chronic hives.  Started 11/20 - visited urgent care - prescribed a steroid .  PCP visit on 12/29 - referred to allergist. Allergist visit on 2/10/23 - allergist concluded allergies were not cause, and was an internal problem.   Hives have continued to be present and had no prior history.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Biopsy skin abnormal, Dermatitis, Ocular hyperaemia, Rash
Clinical narrative: I had a rash all over my arms, my legs, my crotch, my nose, my eyes, my ears, and my scalp. It continued to get worse. I will call back to provide LOT number for vaccine. My eyes were starting to get really red and I saw the doctor for the skin rash.
Age: 70.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Headache, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: Started having a headache, congestion and a cough. Took Home Antigen COVID test and it was positive. Called Doctor but decided not to get a prescription and just rested. Took another COVID-19 test on 01/25/2023 and it was negative.
Age: 68.0
Sex: U
Vaccine: COVID19-2
Symptoms: Product storage error
Clinical narrative: temp exclusion
Age: 8.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: When the appointment was booked, the father accidentally booked her for a second dose appointment, instead of a bivalent booster. She was meant to have the bivalent booster. At the site this was not communicated, and the patient received a primary series dose instead of the bivalent booster. There were no physical adverse events caused by the dose given.
Age: 61.0
Sex: F
Vaccine: VARZOS
Symptoms: Headache, Injection site rash, Injection site scab, Myalgia, Nausea
Clinical narrative: I got the shot on 1/26/23.  Over the next 24-48 hours I experienced mild nausea, definite muscle aches, and a moderate headache.   I also noticed that for a short while (<1 hour) my lips felt a little thick, but not enough to alarm me.  Since the injection I have also developed a few small hives on my face and scalp.  The injection site developed a sore much like the shingles rash itself which scabbed over and is mostly healed now.   Since I have many allergies (I carry an epipen), I am not sure if these "itchies" were from the vaccine or something else in my environment.
Age: 61.0
Sex: F
Vaccine: VARZOS
Symptoms: Oral discomfort, Pruritus, Urticaria
Clinical narrative: I got the shot on 1/26/23.  Over the next 24-48 hours I experienced mild nausea, definite muscle aches, and a moderate headache.   I also noticed that for a short while (<1 hour) my lips felt a little thick, but not enough to alarm me.  Since the injection I have also developed a few small hives on my face and scalp.  The injection site developed a sore much like the shingles rash itself which scabbed over and is mostly healed now.   Since I have many allergies (I carry an epipen), I am not sure if these "itchies" were from the vaccine or something else in my environment.
Age: 29.0
Sex: F
Vaccine: VARCEL
Symptoms: Burning sensation, Pain of skin, Rash, Throat irritation
Clinical narrative: About 2 hours after the vaccine, the person reports that she had a burning stinging sensation to her face, and developed a rash.  She reports this is spread to her chest, and she has some itching and scratching in her throat.  She denies any trouble breathing, she has not had any vomiting or diarrhea.  Person presented to the ED at 2018.   Person took Benadryl at home and was provided prednisone in the Emergency Department.  Person was discharged home.
Age: 77.0
Sex: U
Vaccine: COVID19-2
Symptoms: Unevaluable event
Clinical narrative: None stated.
Age: 57.0
Sex: F
Vaccine: VARZOS
Symptoms: Feeding disorder, Injection site erythema, Injection site mass, Injection site pain, Injection site swelling
Clinical narrative: Large red, painful, swollen lump at injection site; 99.4-degree fever X 2 days, nausea, vomiting X 2, inability to eat, muscle pain in upper body.
Age: 57.0
Sex: F
Vaccine: VARZOS
Symptoms: Myalgia, Nausea, Pyrexia, Vomiting
Clinical narrative: Large red, painful, swollen lump at injection site; 99.4-degree fever X 2 days, nausea, vomiting X 2, inability to eat, muscle pain in upper body.
Age: 78.0
Sex: U
Vaccine: COVID19-2
Symptoms: Product storage error
Clinical narrative: temp exlcusioni
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Extra dose administered, Wrong product administered
Clinical narrative: Patient did not have any adverse event, but this was the 3rd Shingrix vaccine patient received.  She should not have received this vaccine.   She should have received another vaccine.
Age: 90.0
Sex: M
Vaccine: COVID19, COVID19, COVID19-2
Symptoms: Asthenia, Intensive care, Syncope
Clinical narrative: Case developed weakness with syncope at home, beginning 01/30/2023. It occurred again 01/31/2023 when case was transported via ambulance to a local Hospital where he remains in ICU.
Age: 1.67
Sex: F
Vaccine: DTAP, HEPA, HIBV, MMR, PNC13, VARCEL
Symptoms: Expired product administered
Clinical narrative: This was a vaccine error.   DTap (Infanrix) was expired by 2 days.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Weight decreased
Clinical narrative: It kind of built up I just noticed it more lately. The chest pain has moved over from my left side to my right. Over the last month and a half I have cut my metoprolol dose in  half and here lately having these chest pains I do not understand as I have been healthy my whole life I am loosing weight as I know this is a factor as well and now I am back to normal weight or almost to where I should be.
Age: 11.0
Sex: F
Vaccine: DTAPIPV, HEP, HEPA, MMRV
Symptoms: Dizziness, Supine position, Syncope
Clinical narrative: Upon administration of Kinrix in left deltoid, patient experienced a syncopal episode. This was the fourth and final vaccine administered at this visit. Patient collapsed backwards onto exam table. Dr. was called in to examine. Dr. determined this to be a syncopal episode. Patient was not postictal and was not presenting with signs of anaphylactic reaction. Pt was alert and conscious after approximately 30 seconds from time of syncopal episode. Patient reported experiencing dizziness and light-headedness. Patient was positioned supine for 30 minutes. Patient drank juice box and reported resolution of symptoms. Patient was monitored for a total of 40 minutes from time of episode. Patient was able to ambulate normally and went home.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Back pain, Chest pain, Computerised tomogram thorax abnormal, Dyspnoea, Dyspnoea exertional
Clinical narrative: May 15, 2021 woke up with chest pain and pain in back between shoulder blades.  Sought medical care x 2 with Dr. Obtained EKG (normal) and diagnosed acid reflux and/or related to shoulder injury or RA. Prescribed Omeprazole which did not help. July 2021 was being physically active and noticed SOB, fatigue, chest pain, back pain, resting pulse of 140's. Mid July saw Dr. at local Healthcare as syptoms had increased. She did an EKG-normal, blood work with elevated Ddimer of 2400 and sent her to the ER. ER completed a CT scan to rule out a blood clot and found the pericarditis. Hospitalized overnight, echocardiogram was given the next day and found she could be released. Followed up w
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Echocardiogram, Electrocardiogram normal, Fatigue, Fibrin D dimer increased, Gastrooesophageal reflux disease
Clinical narrative: May 15, 2021 woke up with chest pain and pain in back between shoulder blades.  Sought medical care x 2 with Dr. Obtained EKG (normal) and diagnosed acid reflux and/or related to shoulder injury or RA. Prescribed Omeprazole which did not help. July 2021 was being physically active and noticed SOB, fatigue, chest pain, back pain, resting pulse of 140's. Mid July saw Dr. at local Healthcare as syptoms had increased. She did an EKG-normal, blood work with elevated Ddimer of 2400 and sent her to the ER. ER completed a CT scan to rule out a blood clot and found the pericarditis. Hospitalized overnight, echocardiogram was given the next day and found she could be released. Followed up w
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Musculoskeletal pain, Pericarditis
Clinical narrative: May 15, 2021 woke up with chest pain and pain in back between shoulder blades.  Sought medical care x 2 with Dr. Obtained EKG (normal) and diagnosed acid reflux and/or related to shoulder injury or RA. Prescribed Omeprazole which did not help. July 2021 was being physically active and noticed SOB, fatigue, chest pain, back pain, resting pulse of 140's. Mid July saw Dr. at local Healthcare as syptoms had increased. She did an EKG-normal, blood work with elevated Ddimer of 2400 and sent her to the ER. ER completed a CT scan to rule out a blood clot and found the pericarditis. Hospitalized overnight, echocardiogram was given the next day and found she could be released. Followed up w
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Aortic arteriosclerosis, Arteriosclerosis coronary artery, Blood culture negative, Blood lactic acid increased, COVID-19
Clinical narrative: Patient is a 38 Y female with h/o DM2, HTN, GERD, Mirena IUD in place, obesity, recurrent UTIs, who presented to the ED with 1 day of fever/chills, diaphoresis, generally feeling ill, and tachycardia.    Met sepsis criteria with sinus tachycardia to 170s, tachypnea, fever to 101.7 and WBC 25.9, with lactate 4.7. No clear localizing signs of infection. Covid positive. RSV/flu negative. UA with 24 WBCs, 6 RBCs, 270 squamous cells -- possible contamination. Urine culture no growth. Blood cultures no growth to date. CT chest/abd/pelvis showed no PE but did show scattered areas of consolidation in the lungs concerning for infection/inflammation as well as skin thickening around the umbilicus, although no clinical signs of cellulitis. CT also noted aortic and coronary artery atherosclerosis. Complained of left flank dull pain throughout admission, although urine culture negative and no CVA tenderness. No genital pain or rash concerning for Fournier's gangrene.   Admitted for septic shock and treated with IV fluids and IV ceftriaxone and PO doxycycline (1/29- ) for possible pyelnonephritis vs community acquired pneumonia as well as remdesivir (1/29- ) for Covid without hypoxia. Lactate normalized and WBC downtrending. Patient evaluated for ACAH and was accepted into the program. She appeared well on day of discharge, was walking around without issue, tolerating PO, and wanted to go home.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Chills, Computerised tomogram abdomen abnormal, Computerised tomogram thorax abnormal, Culture urine negative, Flank pain
Clinical narrative: Patient is a 38 Y female with h/o DM2, HTN, GERD, Mirena IUD in place, obesity, recurrent UTIs, who presented to the ED with 1 day of fever/chills, diaphoresis, generally feeling ill, and tachycardia.    Met sepsis criteria with sinus tachycardia to 170s, tachypnea, fever to 101.7 and WBC 25.9, with lactate 4.7. No clear localizing signs of infection. Covid positive. RSV/flu negative. UA with 24 WBCs, 6 RBCs, 270 squamous cells -- possible contamination. Urine culture no growth. Blood cultures no growth to date. CT chest/abd/pelvis showed no PE but did show scattered areas of consolidation in the lungs concerning for infection/inflammation as well as skin thickening around the umbilicus, although no clinical signs of cellulitis. CT also noted aortic and coronary artery atherosclerosis. Complained of left flank dull pain throughout admission, although urine culture negative and no CVA tenderness. No genital pain or rash concerning for Fournier's gangrene.   Admitted for septic shock and treated with IV fluids and IV ceftriaxone and PO doxycycline (1/29- ) for possible pyelnonephritis vs community acquired pneumonia as well as remdesivir (1/29- ) for Covid without hypoxia. Lactate normalized and WBC downtrending. Patient evaluated for ACAH and was accepted into the program. She appeared well on day of discharge, was walking around without issue, tolerating PO, and wanted to go home.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Hyperhidrosis, Influenza virus test negative, Lung consolidation, Malaise, Pain
Clinical narrative: Patient is a 38 Y female with h/o DM2, HTN, GERD, Mirena IUD in place, obesity, recurrent UTIs, who presented to the ED with 1 day of fever/chills, diaphoresis, generally feeling ill, and tachycardia.    Met sepsis criteria with sinus tachycardia to 170s, tachypnea, fever to 101.7 and WBC 25.9, with lactate 4.7. No clear localizing signs of infection. Covid positive. RSV/flu negative. UA with 24 WBCs, 6 RBCs, 270 squamous cells -- possible contamination. Urine culture no growth. Blood cultures no growth to date. CT chest/abd/pelvis showed no PE but did show scattered areas of consolidation in the lungs concerning for infection/inflammation as well as skin thickening around the umbilicus, although no clinical signs of cellulitis. CT also noted aortic and coronary artery atherosclerosis. Complained of left flank dull pain throughout admission, although urine culture negative and no CVA tenderness. No genital pain or rash concerning for Fournier's gangrene.   Admitted for septic shock and treated with IV fluids and IV ceftriaxone and PO doxycycline (1/29- ) for possible pyelnonephritis vs community acquired pneumonia as well as remdesivir (1/29- ) for Covid without hypoxia. Lactate normalized and WBC downtrending. Patient evaluated for ACAH and was accepted into the program. She appeared well on day of discharge, was walking around without issue, tolerating PO, and wanted to go home.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Pneumonia, Pyelonephritis, Pyrexia, Red blood cells urine positive, Respiratory syncytial virus test negative
Clinical narrative: Patient is a 38 Y female with h/o DM2, HTN, GERD, Mirena IUD in place, obesity, recurrent UTIs, who presented to the ED with 1 day of fever/chills, diaphoresis, generally feeling ill, and tachycardia.    Met sepsis criteria with sinus tachycardia to 170s, tachypnea, fever to 101.7 and WBC 25.9, with lactate 4.7. No clear localizing signs of infection. Covid positive. RSV/flu negative. UA with 24 WBCs, 6 RBCs, 270 squamous cells -- possible contamination. Urine culture no growth. Blood cultures no growth to date. CT chest/abd/pelvis showed no PE but did show scattered areas of consolidation in the lungs concerning for infection/inflammation as well as skin thickening around the umbilicus, although no clinical signs of cellulitis. CT also noted aortic and coronary artery atherosclerosis. Complained of left flank dull pain throughout admission, although urine culture negative and no CVA tenderness. No genital pain or rash concerning for Fournier's gangrene.   Admitted for septic shock and treated with IV fluids and IV ceftriaxone and PO doxycycline (1/29- ) for possible pyelnonephritis vs community acquired pneumonia as well as remdesivir (1/29- ) for Covid without hypoxia. Lactate normalized and WBC downtrending. Patient evaluated for ACAH and was accepted into the program. She appeared well on day of discharge, was walking around without issue, tolerating PO, and wanted to go home.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Septic shock, Sinus tachycardia, Skin hypertrophy, Tachycardia
Clinical narrative: Patient is a 38 Y female with h/o DM2, HTN, GERD, Mirena IUD in place, obesity, recurrent UTIs, who presented to the ED with 1 day of fever/chills, diaphoresis, generally feeling ill, and tachycardia.    Met sepsis criteria with sinus tachycardia to 170s, tachypnea, fever to 101.7 and WBC 25.9, with lactate 4.7. No clear localizing signs of infection. Covid positive. RSV/flu negative. UA with 24 WBCs, 6 RBCs, 270 squamous cells -- possible contamination. Urine culture no growth. Blood cultures no growth to date. CT chest/abd/pelvis showed no PE but did show scattered areas of consolidation in the lungs concerning for infection/inflammation as well as skin thickening around the umbilicus, although no clinical signs of cellulitis. CT also noted aortic and coronary artery atherosclerosis. Complained of left flank dull pain throughout admission, although urine culture negative and no CVA tenderness. No genital pain or rash concerning for Fournier's gangrene.   Admitted for septic shock and treated with IV fluids and IV ceftriaxone and PO doxycycline (1/29- ) for possible pyelnonephritis vs community acquired pneumonia as well as remdesivir (1/29- ) for Covid without hypoxia. Lactate normalized and WBC downtrending. Patient evaluated for ACAH and was accepted into the program. She appeared well on day of discharge, was walking around without issue, tolerating PO, and wanted to go home.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Tachypnoea, Urinary sediment present, Urine analysis abnormal, White blood cell count increased, White blood cells urine positive
Clinical narrative: Patient is a 38 Y female with h/o DM2, HTN, GERD, Mirena IUD in place, obesity, recurrent UTIs, who presented to the ED with 1 day of fever/chills, diaphoresis, generally feeling ill, and tachycardia.    Met sepsis criteria with sinus tachycardia to 170s, tachypnea, fever to 101.7 and WBC 25.9, with lactate 4.7. No clear localizing signs of infection. Covid positive. RSV/flu negative. UA with 24 WBCs, 6 RBCs, 270 squamous cells -- possible contamination. Urine culture no growth. Blood cultures no growth to date. CT chest/abd/pelvis showed no PE but did show scattered areas of consolidation in the lungs concerning for infection/inflammation as well as skin thickening around the umbilicus, although no clinical signs of cellulitis. CT also noted aortic and coronary artery atherosclerosis. Complained of left flank dull pain throughout admission, although urine culture negative and no CVA tenderness. No genital pain or rash concerning for Fournier's gangrene.   Admitted for septic shock and treated with IV fluids and IV ceftriaxone and PO doxycycline (1/29- ) for possible pyelnonephritis vs community acquired pneumonia as well as remdesivir (1/29- ) for Covid without hypoxia. Lactate normalized and WBC downtrending. Patient evaluated for ACAH and was accepted into the program. She appeared well on day of discharge, was walking around without issue, tolerating PO, and wanted to go home.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Mobility decreased, X-ray
Clinical narrative: I was not able to lift my left arm at all after my vaccine. Slowly over time I began to regain some mobility. It took a year to regain full mobility.
Age: 43.0
Sex: M
Vaccine: UNK
Symptoms: Headache
Clinical narrative: Headache after bivalent covid vaccine
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Fatigue, Nasal congestion, Pyrexia
Clinical narrative: I had a scratchy throat, runny and stuffy nose, coughing, chest congestion, very tired, and low grade fever about 99 degrees. I had like bronchitis like symptoms.  These symptoms progressed thought time I had COVID-19.  I called my doctor and he prescribed Z-pack and Prednisone.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Respiratory symptom, Respiratory tract congestion, Rhinorrhoea, SARS-CoV-2 test positive, Throat irritation
Clinical narrative: I had a scratchy throat, runny and stuffy nose, coughing, chest congestion, very tired, and low grade fever about 99 degrees. I had like bronchitis like symptoms.  These symptoms progressed thought time I had COVID-19.  I called my doctor and he prescribed Z-pack and Prednisone.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Laboratory test
Clinical narrative: No sx, pt tested before surgery.
Age: 50.0
Sex: F
Vaccine: COVID19-2
Symptoms: Abdominal pain upper, Colitis, Faecal vomiting, Intestinal obstruction, Nausea
Clinical narrative: I felt a little achy after receiving the vaccine for a couple of days. On 11/07/2022, I work up with severe gastric pain, vomiting, nausea and the smell was terrible. I was vomiting feces.  I went to the emergency room and then they transferred me to a hospital. I stayed for three days. I was diagnosed colitis with a blockage. I am scheduled for surgery soon.
Age: 50.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pain, Vomiting
Clinical narrative: I felt a little achy after receiving the vaccine for a couple of days. On 11/07/2022, I work up with severe gastric pain, vomiting, nausea and the smell was terrible. I was vomiting feces.  I went to the emergency room and then they transferred me to a hospital. I stayed for three days. I was diagnosed colitis with a blockage. I am scheduled for surgery soon.
Age: 1.83
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine (expiration date 2/8/2023) administered to the patient on 2/9/2023.
Age: 20.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired vaccine administered. No known abnormal signs/ symptoms on patient.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Death, SARS-CoV-2 test positive, Unresponsive to stimuli
Clinical narrative: Pt tested positive for COVID ON 8/25/22  at home; discovered unresponsive at her home on 8/27/22; pt deceased; Medical Examiner stated COD:  COVID 19 viral infection
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Asthenia, Chills, Nausea, Sleep disorder, Thirst
Clinical narrative: Uncontrolld shivering, nausea, weakness, vertigo, thirst, disturbed sleep for 24 hrs.
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Vertigo
Clinical narrative: Uncontrolld shivering, nausea, weakness, vertigo, thirst, disturbed sleep for 24 hrs.
Age: 8.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Blood glucose normal, Dehydration, Fatigue, Hypophagia
Clinical narrative: I went to dinner with my son at a restaurant on 1/23/2023. As we were on our way there, my son alerted me that he had thrown up earlier that day after lunch at school. I thought that maybe it was because of the food served by the school, because he is a vegetarian, and he previously had vomited after eating food with meat in it. He told me that he felt fine, but while we were at the restaurant, he took just a few bites before he threw up profusely. We ended up having to leave, so we then went home. I tried giving him liquid hydration, but he threw that up, too. I kept him home from school the next day to monitor him. He ate soup and crackers that day, and he was able to keep them down. I gave him some carbonated coconut water, and he felt fine after that. Four days later, his 17-month-old brother also got sick, only he had both diarrhea and vomiting for two days. I knew then that the symptoms weren't caused by food.  On 1/29/2023 at around 6 PM, my son began vomiting profusely again, and so did his sister. I gave my son vegetable broth, electrolyte drink, water, carbonated coconut water, and crackers, but he kept throwing them up. He got to the point at which he was actually throwing up what I later found out to be bile. He became weak and very fatigued, which is unusual for him, as he is normally high-energy. I took my son to the doctor on 1/31/2023, I took my son to the doctor; by this point, my daughter had recovered and was back in school, but my son's vomiting continued. The doctor checked my son and said that he was extremely dehydrated. She told me that I needed to give him 60 oz of liquid; otherwise, he would have to go to the hospital and put on an IV. She gave me a plan to give him the 60 oz of fluid, plus some antinausea medication. I gave my son his first dose of the antinausea medication about 12 PM that day. I was able to give him the 60 oz of liquid, which he was able to keep down. At this point, though, he could not eat solid food. He was just able to consume liquids. Later that evening, he was able to eat crackers and soup and keep them down. The doctor advised me to keep him home from school for one more day to make sure he was able to eat solid food and keep it down, which he was. My son returned to school on 2/2/2023.
Age: 8.0
Sex: M
Vaccine: COVID19
Symptoms: Loss of personal independence in daily activities, Vomiting
Clinical narrative: I went to dinner with my son at a restaurant on 1/23/2023. As we were on our way there, my son alerted me that he had thrown up earlier that day after lunch at school. I thought that maybe it was because of the food served by the school, because he is a vegetarian, and he previously had vomited after eating food with meat in it. He told me that he felt fine, but while we were at the restaurant, he took just a few bites before he threw up profusely. We ended up having to leave, so we then went home. I tried giving him liquid hydration, but he threw that up, too. I kept him home from school the next day to monitor him. He ate soup and crackers that day, and he was able to keep them down. I gave him some carbonated coconut water, and he felt fine after that. Four days later, his 17-month-old brother also got sick, only he had both diarrhea and vomiting for two days. I knew then that the symptoms weren't caused by food.  On 1/29/2023 at around 6 PM, my son began vomiting profusely again, and so did his sister. I gave my son vegetable broth, electrolyte drink, water, carbonated coconut water, and crackers, but he kept throwing them up. He got to the point at which he was actually throwing up what I later found out to be bile. He became weak and very fatigued, which is unusual for him, as he is normally high-energy. I took my son to the doctor on 1/31/2023, I took my son to the doctor; by this point, my daughter had recovered and was back in school, but my son's vomiting continued. The doctor checked my son and said that he was extremely dehydrated. She told me that I needed to give him 60 oz of liquid; otherwise, he would have to go to the hospital and put on an IV. She gave me a plan to give him the 60 oz of fluid, plus some antinausea medication. I gave my son his first dose of the antinausea medication about 12 PM that day. I was able to give him the 60 oz of liquid, which he was able to keep down. At this point, though, he could not eat solid food. He was just able to consume liquids. Later that evening, he was able to eat crackers and soup and keep them down. The doctor advised me to keep him home from school for one more day to make sure he was able to eat solid food and keep it down, which he was. My son returned to school on 2/2/2023.
Age: 83.0
Sex: M
Vaccine: COVID19, COVID19, COVID19-2, COVID19-2
Symptoms: COVID-19, Cholelithiasis, Exposure to SARS-CoV-2, Mental status changes, Pyrexia
Clinical narrative: 85-year-old male, resident of boarding care facility, history of diastolic heart failure, benign neoplasm of the pituitary gland, history of gastrointestinal stromal tumor/stomach cancer, GERD with esophageal stricture, previous lacunar infarct, HLD, male hypogonadism failure on long-term testosterone, who presented from skilled nursing facility on 02/01 due to change in mental status along with fever.  Although he tested negative for COVID at the boarding care facility, he tested positive in the ED 02/01.  No further information it is revealed that his roommate was positive.  Onset of his own symptoms was not clear.  He was noted to have elevation of transaminases but no hypoxemia.  Hence he was started on remdesivir but not steroid.  Ultrasound of his right upper quadrant revealed the presence of cholelithiasis which were previously known without thickening of the gallbladder wall but they were unable to assess for Murphy sign sonographically.  Clinically he did not not meet criteria for cholecystitis.  Transaminase elevation improved significantly.  His mental status also improved dramatically within 24 hours.
Age: 83.0
Sex: M
Vaccine: COVID19, COVID19, COVID19-2, COVID19-2
Symptoms: SARS-CoV-2 test positive, Transaminases increased
Clinical narrative: 85-year-old male, resident of boarding care facility, history of diastolic heart failure, benign neoplasm of the pituitary gland, history of gastrointestinal stromal tumor/stomach cancer, GERD with esophageal stricture, previous lacunar infarct, HLD, male hypogonadism failure on long-term testosterone, who presented from skilled nursing facility on 02/01 due to change in mental status along with fever.  Although he tested negative for COVID at the boarding care facility, he tested positive in the ED 02/01.  No further information it is revealed that his roommate was positive.  Onset of his own symptoms was not clear.  He was noted to have elevation of transaminases but no hypoxemia.  Hence he was started on remdesivir but not steroid.  Ultrasound of his right upper quadrant revealed the presence of cholelithiasis which were previously known without thickening of the gallbladder wall but they were unable to assess for Murphy sign sonographically.  Clinically he did not not meet criteria for cholecystitis.  Transaminase elevation improved significantly.  His mental status also improved dramatically within 24 hours.
Age: 83.0
Sex: F
Vaccine: COVID19-2
Symptoms: Cyanosis, Death, Unresponsive to stimuli
Clinical narrative: Received vaccine on 2/3/23 and then on 2/6/23  in am when up for breakfast was noted to cyanotic and unresponsive, was assisted into bed and passed away.  There is no evidence that her death is related  to vaccine other than timing.
Age: 92.0
Sex: F
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Asymptomatic COVID-19, Chest discomfort, Dyspnoea, Exposure to SARS-CoV-2
Clinical narrative: The patient is 94 F with history of HTN, CHF (HFpEF), DM2, CAD with stent who presented with complaints of left sided chest pressure and shortness of breath. +Trop admitted for possible NSTEMI. Seen by cardiology who recommends medical management for Type 2 MI. Patient also incidentally found to be COVID + on 2/1 swab. Family exposure.  She is asymptomatic (receiving RDV while IP, does not need stay for this medication in the hospital in particular). Possible DC with Paxlovid after risk benefit d/w family. Will have 24 hours heparin gtt. Started on Imdur. Cards feel DAPT not needed, can continue her prior Plavix only.               Possible DC on 2/3 after oncoming HBS evaluates the patient.                Isolation will end on 2/11 based on swab given patient asymptomatic
Age: 92.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Troponin increased
Clinical narrative: The patient is 94 F with history of HTN, CHF (HFpEF), DM2, CAD with stent who presented with complaints of left sided chest pressure and shortness of breath. +Trop admitted for possible NSTEMI. Seen by cardiology who recommends medical management for Type 2 MI. Patient also incidentally found to be COVID + on 2/1 swab. Family exposure.  She is asymptomatic (receiving RDV while IP, does not need stay for this medication in the hospital in particular). Possible DC with Paxlovid after risk benefit d/w family. Will have 24 hours heparin gtt. Started on Imdur. Cards feel DAPT not needed, can continue her prior Plavix only.               Possible DC on 2/3 after oncoming HBS evaluates the patient.                Isolation will end on 2/11 based on swab given patient asymptomatic
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Anticoagulant therapy, Atrial fibrillation, Blood culture negative, COVID-19
Clinical narrative: 90 year old male with history of afib on coumadin, hypothyroidism, dysphagia with chronic PEG, hydronephrosis with foley, CKD stage 3, AAA, interstitial lung disease, left tibia fracture 12/6/-2022,  recent respiratory failure due to Covid disease (admission 12/27/2022-1/3/2023), presented on 2/1/2023 for shortness of breath and productive cough and found to have O2 saturation 86%, AKI, hyponatremia and septic shock/respiratory failure requiring bipap, antibiotics, norepinephrine and admitted to the intensive care unit.  He was treated for post Covid community acquired pneumonia, Proteus UTI.  Renal ultrasound showed no hydronephrosis.  Urine culture sensitivities pending (had Proteus and E. coli UTI 8/8/2022 susceptible to Zosyn at the time), blood cultures negative to date.  Patient with atrial fibrillation RVR and started on amiodarone gtt.  Echocardiogram showed severe cardiac dysfunction with EF 20-25% and regional wall motion abnormalities.  Coagulopathy with elevated INR likely due to warfarin along with acute illness and medications.  Status post vitamin K x2.  Given patient's poor pre-existing condition, family change CODE STATUS to DNR/DNI.  Palliative care consulted for support and symptomatic respiratory relief.  Family desires home hospice comfort care approach as want to be with family.
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac dysfunction, Coagulopathy, Culture urine, Dyspnoea, Echocardiogram abnormal
Clinical narrative: 90 year old male with history of afib on coumadin, hypothyroidism, dysphagia with chronic PEG, hydronephrosis with foley, CKD stage 3, AAA, interstitial lung disease, left tibia fracture 12/6/-2022,  recent respiratory failure due to Covid disease (admission 12/27/2022-1/3/2023), presented on 2/1/2023 for shortness of breath and productive cough and found to have O2 saturation 86%, AKI, hyponatremia and septic shock/respiratory failure requiring bipap, antibiotics, norepinephrine and admitted to the intensive care unit.  He was treated for post Covid community acquired pneumonia, Proteus UTI.  Renal ultrasound showed no hydronephrosis.  Urine culture sensitivities pending (had Proteus and E. coli UTI 8/8/2022 susceptible to Zosyn at the time), blood cultures negative to date.  Patient with atrial fibrillation RVR and started on amiodarone gtt.  Echocardiogram showed severe cardiac dysfunction with EF 20-25% and regional wall motion abnormalities.  Coagulopathy with elevated INR likely due to warfarin along with acute illness and medications.  Status post vitamin K x2.  Given patient's poor pre-existing condition, family change CODE STATUS to DNR/DNI.  Palliative care consulted for support and symptomatic respiratory relief.  Family desires home hospice comfort care approach as want to be with family.
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Escherichia infection, Hyponatraemia, Intensive care, International normalised ratio increased, Pneumonia
Clinical narrative: 90 year old male with history of afib on coumadin, hypothyroidism, dysphagia with chronic PEG, hydronephrosis with foley, CKD stage 3, AAA, interstitial lung disease, left tibia fracture 12/6/-2022,  recent respiratory failure due to Covid disease (admission 12/27/2022-1/3/2023), presented on 2/1/2023 for shortness of breath and productive cough and found to have O2 saturation 86%, AKI, hyponatremia and septic shock/respiratory failure requiring bipap, antibiotics, norepinephrine and admitted to the intensive care unit.  He was treated for post Covid community acquired pneumonia, Proteus UTI.  Renal ultrasound showed no hydronephrosis.  Urine culture sensitivities pending (had Proteus and E. coli UTI 8/8/2022 susceptible to Zosyn at the time), blood cultures negative to date.  Patient with atrial fibrillation RVR and started on amiodarone gtt.  Echocardiogram showed severe cardiac dysfunction with EF 20-25% and regional wall motion abnormalities.  Coagulopathy with elevated INR likely due to warfarin along with acute illness and medications.  Status post vitamin K x2.  Given patient's poor pre-existing condition, family change CODE STATUS to DNR/DNI.  Palliative care consulted for support and symptomatic respiratory relief.  Family desires home hospice comfort care approach as want to be with family.
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Positive airway pressure therapy, Productive cough, Proteus infection, Respiratory failure, Septic shock
Clinical narrative: 90 year old male with history of afib on coumadin, hypothyroidism, dysphagia with chronic PEG, hydronephrosis with foley, CKD stage 3, AAA, interstitial lung disease, left tibia fracture 12/6/-2022,  recent respiratory failure due to Covid disease (admission 12/27/2022-1/3/2023), presented on 2/1/2023 for shortness of breath and productive cough and found to have O2 saturation 86%, AKI, hyponatremia and septic shock/respiratory failure requiring bipap, antibiotics, norepinephrine and admitted to the intensive care unit.  He was treated for post Covid community acquired pneumonia, Proteus UTI.  Renal ultrasound showed no hydronephrosis.  Urine culture sensitivities pending (had Proteus and E. coli UTI 8/8/2022 susceptible to Zosyn at the time), blood cultures negative to date.  Patient with atrial fibrillation RVR and started on amiodarone gtt.  Echocardiogram showed severe cardiac dysfunction with EF 20-25% and regional wall motion abnormalities.  Coagulopathy with elevated INR likely due to warfarin along with acute illness and medications.  Status post vitamin K x2.  Given patient's poor pre-existing condition, family change CODE STATUS to DNR/DNI.  Palliative care consulted for support and symptomatic respiratory relief.  Family desires home hospice comfort care approach as want to be with family.
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Tibia fracture, Ultrasound kidney normal, Urinary tract infection
Clinical narrative: 90 year old male with history of afib on coumadin, hypothyroidism, dysphagia with chronic PEG, hydronephrosis with foley, CKD stage 3, AAA, interstitial lung disease, left tibia fracture 12/6/-2022,  recent respiratory failure due to Covid disease (admission 12/27/2022-1/3/2023), presented on 2/1/2023 for shortness of breath and productive cough and found to have O2 saturation 86%, AKI, hyponatremia and septic shock/respiratory failure requiring bipap, antibiotics, norepinephrine and admitted to the intensive care unit.  He was treated for post Covid community acquired pneumonia, Proteus UTI.  Renal ultrasound showed no hydronephrosis.  Urine culture sensitivities pending (had Proteus and E. coli UTI 8/8/2022 susceptible to Zosyn at the time), blood cultures negative to date.  Patient with atrial fibrillation RVR and started on amiodarone gtt.  Echocardiogram showed severe cardiac dysfunction with EF 20-25% and regional wall motion abnormalities.  Coagulopathy with elevated INR likely due to warfarin along with acute illness and medications.  Status post vitamin K x2.  Given patient's poor pre-existing condition, family change CODE STATUS to DNR/DNI.  Palliative care consulted for support and symptomatic respiratory relief.  Family desires home hospice comfort care approach as want to be with family.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Appendicitis, Asymptomatic COVID-19, SARS-CoV-2 test positive, White blood cell count normal
Clinical narrative: Admit w uncomplicated actue appendicitis. Opted for non-operative management due to COVID+ (asymptomatic). Uneventful recovery. Pain free, nml WBC at time of discharge. Home on 5 days oral abx
Age: 5.0
Sex: F
Vaccine: MMRV
Symptoms: Expired product administered
Clinical narrative: I had drawn up the vaccine and administered it. I was putting the data in the system and did not realize the vaccines expiration date was 12/15/2022.
Age: 1.0
Sex: M
Vaccine: MMR, VARCEL, MMR, VARCEL
Symptoms: Product administration error
Clinical narrative: Administration Error - Vaccines MMR and Varivax were ordered separately, Medical Assistant drew both MMR an Varivax vials together and administrated as a combo in one syringe.  As of today,  patient has not had any adverse reaction.    Awaiting guidance from Merck Co.  regarding whether mixing vaccines will null efficacy, whether patient will need another dose
Age: 1.0
Sex: M
Vaccine: MMR, VARCEL, MMR, VARCEL
Symptoms: No adverse event, Product preparation issue, Wrong technique in product usage process
Clinical narrative: Administration Error - Vaccines MMR and Varivax were ordered separately, Medical Assistant drew both MMR an Varivax vials together and administrated as a combo in one syringe.  As of today,  patient has not had any adverse reaction.    Awaiting guidance from Merck Co.  regarding whether mixing vaccines will null efficacy, whether patient will need another dose
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Blood sodium decreased, COVID-19, Dyspnoea exertional, Fall
Clinical narrative: 89-year-old female with past medical history of HFpEF, severe tricuspid regurgitation with pulmonary hypertension and right-sided heart failure, atrial fibrillation on Coumadin, iron deficiency anemia, chronic kidney disease stage 3a, liver cirrhosis, hypertension, recent admission 1/10/2023 to 1/19/2023 for  Fall s/p left femur fracture and had intramedullary rod placement on 1/11/2023.  Her course was complicated by hyponatremia and postoperative blood loss for which she required blood transfusions.  Her hyponatremia was thought to be due to hypovolemic hyponatremia with component of SIADH from postoperative pain and she was on salt tablets which were stopped on 1/17/2023.  Coumadin resumed.  Patient was sent to rehab facility. Patient's sodium was being monitored outpatient and  She had Na of 126 on 1/30/23 and repeat sodium yesterday 121.  She was therefore transferred to ED for dyspnea on exertion and LE edema and 30# weight gain. Weight of 150 lbs on 1/11/23 and 184 lbs on 1/30/2023.   She tested positive for Covid but no cough and no hypoxia. Started on Remdesivit 2/3-2/7 last dose12:30 pm. Admitted for diuresis on lasix gtt. Much improved, renal function stable. 12L urine output from admission to 2/6. Change to oral lasix 80 mg BID 2/6 to see if will continue to respond well on orals. She could probably go home on 40 mg BID with extra 0.5 tablet of 80 mg lasix if shortness of breath, LE edema, 2# weight gain.  Patient hoping to go home 2/7/2023.  Isolation through 2/12/2023
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Femur fracture, Hyponatraemia, Hypovolaemia, Inappropriate antidiuretic hormone secretion, Intramedullary rod insertion
Clinical narrative: 89-year-old female with past medical history of HFpEF, severe tricuspid regurgitation with pulmonary hypertension and right-sided heart failure, atrial fibrillation on Coumadin, iron deficiency anemia, chronic kidney disease stage 3a, liver cirrhosis, hypertension, recent admission 1/10/2023 to 1/19/2023 for  Fall s/p left femur fracture and had intramedullary rod placement on 1/11/2023.  Her course was complicated by hyponatremia and postoperative blood loss for which she required blood transfusions.  Her hyponatremia was thought to be due to hypovolemic hyponatremia with component of SIADH from postoperative pain and she was on salt tablets which were stopped on 1/17/2023.  Coumadin resumed.  Patient was sent to rehab facility. Patient's sodium was being monitored outpatient and  She had Na of 126 on 1/30/23 and repeat sodium yesterday 121.  She was therefore transferred to ED for dyspnea on exertion and LE edema and 30# weight gain. Weight of 150 lbs on 1/11/23 and 184 lbs on 1/30/2023.   She tested positive for Covid but no cough and no hypoxia. Started on Remdesivit 2/3-2/7 last dose12:30 pm. Admitted for diuresis on lasix gtt. Much improved, renal function stable. 12L urine output from admission to 2/6. Change to oral lasix 80 mg BID 2/6 to see if will continue to respond well on orals. She could probably go home on 40 mg BID with extra 0.5 tablet of 80 mg lasix if shortness of breath, LE edema, 2# weight gain.  Patient hoping to go home 2/7/2023.  Isolation through 2/12/2023
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Oedema peripheral, Post procedural haemorrhage, Procedural pain, Renal function test normal, SARS-CoV-2 test positive
Clinical narrative: 89-year-old female with past medical history of HFpEF, severe tricuspid regurgitation with pulmonary hypertension and right-sided heart failure, atrial fibrillation on Coumadin, iron deficiency anemia, chronic kidney disease stage 3a, liver cirrhosis, hypertension, recent admission 1/10/2023 to 1/19/2023 for  Fall s/p left femur fracture and had intramedullary rod placement on 1/11/2023.  Her course was complicated by hyponatremia and postoperative blood loss for which she required blood transfusions.  Her hyponatremia was thought to be due to hypovolemic hyponatremia with component of SIADH from postoperative pain and she was on salt tablets which were stopped on 1/17/2023.  Coumadin resumed.  Patient was sent to rehab facility. Patient's sodium was being monitored outpatient and  She had Na of 126 on 1/30/23 and repeat sodium yesterday 121.  She was therefore transferred to ED for dyspnea on exertion and LE edema and 30# weight gain. Weight of 150 lbs on 1/11/23 and 184 lbs on 1/30/2023.   She tested positive for Covid but no cough and no hypoxia. Started on Remdesivit 2/3-2/7 last dose12:30 pm. Admitted for diuresis on lasix gtt. Much improved, renal function stable. 12L urine output from admission to 2/6. Change to oral lasix 80 mg BID 2/6 to see if will continue to respond well on orals. She could probably go home on 40 mg BID with extra 0.5 tablet of 80 mg lasix if shortness of breath, LE edema, 2# weight gain.  Patient hoping to go home 2/7/2023.  Isolation through 2/12/2023